Using Tumor Necrosis Factor Inhibitors Decreases Risk of Heart Attacks in Rheumatoid Arthritis Patients
American College of Rheumatology (ACR)Rheumatoid arthritis patients who use tumor necrosis factor inhibitors (called Anti-TNFs) to control their disease-related inflammation also have a decreased risk for heart attacks, according to research findings presented this week at the American College of Rheumatology Annual Meeting in San Diego.